RBC Global Asset Management

RBC Global Asset Management is the asset management business of Royal Bank of Canada, providing mutual funds, ETFs, institutional investment solutions, private market strategies, and portfolio management services. The firm manages investment capabilities across equities, fixed income, multi-asset, quantitative strategies, private markets, and alternatives, serving individual, intermediary, and institutional clients. It is not a biotech, pharma, or healthcare operating company; rather, it is a financial services company that may offer investment products with exposure to healthcare and life sciences sectors. The business operates under the RBC GAM brand and includes affiliated capabilities such as BlueBay and PH&N. For a biotech analyst, the key point is that RBC Global Asset Management is an investor and fund manager, not a developer of therapeutics, diagnostics, or medical technologies.